A two day national seminar on “Sterile Products – Infrastructure Design & Technological Advances”, conducted by the Controlled Release Society, India Chapter(CRS -IC) and NIPER, Hyderabad, will be held on 14th and 15th September, 2017, at NIPER, Hyderabad.
It will be inaugurated by Dr. Chandrakant Kokate, Vice Chancellor, KLE Deemed University, Belagavi, India.
The seminar intends to cover a wide range of topics ranging from design of aseptic manufacturing facility to innovations in packaging of aseptic products and various novel sterile dosage forms. Regulatory understanding of sterile products would also be covered. The seminar will benefit students, academicians, researchers and industry personnel working with development, manufacture and marketing of sterile dosage forms.
Sterile dosage forms have always been an important class of pharmaceutical products in disease diagnosis, therapy and nutrition. Administration of drugs by parenteral route has skyrocketed over the past several years and will continue to do so. A primary explanation for this enormous growth lies with the advent of biotechnology, the products of which are biomolecules that cannot be readily administered by any other route because of bioavailability and stability reasons.
Hence, it is safe to state that the number of injectable products being developed will significantly increase in the years to come. Perhaps by 2020, the market share of sterile drug products will approximately be the same as that for solid oral dosage forms.
Keeping in mind the need of the hour, this workshop aims at educating and familiarizing the audience with the various aspects of developing and marketing sterile dosage forms.
The keynote speakers are Sudesh Shetty, Partner Risk Consulting, Leads Life Sciences, KPMG, Mumbai, India and Michelle Frisch, Managing Director, Centre of Process Excellence, Pennsylvania, USA.
Scientific abstracts are invited and the last date for submission of abstracts is 10th August 2017. Registration for the seminar is open till 30th August, 2017.
For further information please contact nalini.crs15@gmail.com.